Related Experiment Video
Updated: Jul 1, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
How I approach: the transplant recipient with fever and pulmonary infiltrates
Madan Kumar1, Benjamin R Hanisch2
1Section of Pediatric Infectious Diseases, University of Chicago, Chicago, IL, United States.
Abstract:
Recipients of hematopoietic stem cell transplants and solid organ transplants frequently develop pulmonary infiltrates from both infectious and non-infectious etiologies. Differentiation and further characterization of microbiologic etiologies-viral, bacterial, and fungal-can be exceedingly challenging. Pediatric patients face unique challenges as confirmatory evaluations with bronchoscopy or lung biopsy may be limited. A generalizable approach to diagnosing and managing these conditions has not been well established. This paper aims to summarize our initial clinical approach while discussing the relative evidence informing our practices. A pediatric patient with characteristic infiltrates who has undergone HSCT is presented to facilitate the discussion. Generalizable approaches to similar patients are highlighted as appropriate while highlighting considerations based on clinical course and key risk factors.
Insights
Diagnosing pulmonary infiltrates after stem cell or organ transplants in children is challenging. This paper presents a clinical approach for these complex cases, focusing on infectious and non-infectious causes.
Area of Science:
- Pediatric Medicine
- Pulmonology
- Transplant Medicine
Background:
- Pulmonary infiltrates are common complications in pediatric hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT) recipients.
- Identifying the specific infectious (viral, bacterial, fungal) or non-infectious causes is often difficult.
- Pediatric patients present unique diagnostic challenges due to limitations in invasive procedures like bronchoscopy or lung biopsy.
Purpose of the Study:
- To summarize an initial clinical approach for diagnosing and managing pulmonary infiltrates in pediatric transplant recipients.
- To discuss the evidence base guiding clinical practices for these complex cases.
- To highlight generalizable diagnostic and management strategies, considering clinical course and risk factors.
Main Methods:
- Review of clinical approach and relevant literature.
- Presentation of a case study involving a pediatric HSCT recipient with characteristic pulmonary infiltrates.
- Discussion of diagnostic considerations and management strategies.
Main Results:
- The paper outlines a practical framework for evaluating pulmonary infiltrates in pediatric transplant patients.
- It emphasizes the challenges in differentiating infectious from non-infectious etiologies.
- Key risk factors and clinical course considerations are highlighted.
Conclusions:
- A structured approach is crucial for managing pulmonary infiltrates in pediatric transplant recipients.
- Tailoring diagnostic and therapeutic strategies based on individual patient factors is essential.
- Further research is needed to establish well-defined, generalizable guidelines.
More Related Videos
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
07:37A Rat Lung Transplantation Model of Warm Ischemia/Reperfusion Injury: Optimizations to Improve Outcomes
Published on: October 28, 2021
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: